ACHV
ACHIEVE LIFE SCIENCES, INC.
Key Financials
Operating Income
$19.7M
N/A
Revenue
$0
NaN%
Net Income
$-54648000
↓ 37.2%
EPS (Diluted)
$-1.25
↓ 0.8%
Total Assets
$41.8M
↑ 8.2%
Total Liabilities
$20.3M
↑ 14.3%
Cash & Equivalents
$20.9M
↑ 64.1%
Shareholders' Equity
$21.5M
↑ 3.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/17/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
| 424B5 | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/13/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACHV |
| Company Name | ACHIEVE LIFE SCIENCES, INC. |
| CIK | 949858 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 425-686-1500 |